| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR52A1 |
OR52A1: Olfactory receptor 52A1 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR5V1 |
OR5V1: Olfactory receptor 5V1 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
MCHR1 |
MCHR1, GPR24, SLC1: Melanin-concentrating hormone receptor 1 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR2F1 |
OR2F1, OLF3, OR2F3, OR2F3P, OR2F4, OR2F5: Olfactory receptor 2F1 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
MC2R |
MC2R, ACTHR: Adrenocorticotropic hormone receptor |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
MC3R |
MC3R: Melanocortin receptor 3 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
MC5R |
MC5R: Melanocortin receptor 5 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
BRS3 |
BRS3: Bombesin receptor subtype-3 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
SSTR4 |
SSTR4: Somatostatin receptor type 4 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
MAS1 |
MAS1, MAS: MAS proto-oncogene |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
0.285 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HCRTR2 |
HCRTR2: Orexin receptor type 2 |
0.285 |
Evidence |
|
| CCL25 |
CCL25, SCYA25, TECK: Small-inducible cytokine A25 precursor |
ADORA2A |
ADORA2A, ADORA2: Adenosine receptor A2a |
0.285 |
Evidence |
|
| ADMR |
ADMR: Adrenomedullin receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.285 |
Evidence |
|
| BET1 |
BET1: BET1 homolog |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
0.285 |
Evidence |
|
| BET1 |
BET1: BET1 homolog |
VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
0.285 |
Evidence |
|
| TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
0.285 |
Evidence |
|
| TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
0.285 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
0.285 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
NPY5R |
NPY5R, NPYR5: Neuropeptide Y receptor type 5 |
0.285 |
Evidence |
|